The development of new drugs involves the identification and the evaluation of new/ and current anti-viral compounds based on their activity against a range of viruses with specific mutational patterns compared with the activity of other drugs in the same class.

VIRalliance through its robust assay PHENOSCRIPT™ and its experienced team can provide all the tools and expertise for measuring antiviral drug resistance and other viral characteristics relevant to the development of drugs and vaccines for HIV-1. The evaluation of new agents can be realised at all stages of drug development – pre-clinical, clinical development, post-marketing studies and trend surveys.

PHENOSCRIPT™ is a robust and reliable assay that provides a direct measure of the level of drug susceptibility of a virus and can identify the most effective molecules to suppress viral replication. It can be used to study the evolution of the comportment of a virus in presence of a new inhibitor. A large collection of clinical and laboratory specimens can be used to evaluate the efficacy of new drugs.

PHENOSCRIPT™ is relatively easy and rapid to perform and the interpretation of results, the reproducibility, sensitivity, and accuracy of the assay have all been fully validated.

The highest level of service is provided by a reliable technological platform, which is fully certified with an international accreditation (ISO9001:2002 ).

Through its numerous partnerships with academic centres and other companies, VIRalliance can provide a full testing service including phenotypic and genotypic resistance tests, viral fitness assessments, HIV serology and logistic services. Our research and development team is constantly working to improve PHENOSCRIPT™ and to develop new assays and technologies.

The service provided is delivered from a knowledgeable and experienced team. Our staff has extensive expertise in virology, molecular biology, assay development and clinical research, which enables us to provide the highest quality of service. World-renowned opinion leaders such as Francois Clavel are part of our scientific advisory board.

Our team has the experience to assist at all stages of your research and development projects including design, data analysis, presentation, and publication. Clinical support such as patient selection for clinical trials can also be organised.

Customer satisfaction and quality of results are our main objectives. Our aim is to provide optimal transparency regarding our work and our results, making our customer service exceptional.

Principle of the PHENOSCRIPT™ assay
The PHENOSCRIPT™ report
Important parameters
Comparison with other commercially available tests

To order PHENOSCRIPT™